<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01883492</url>
  </required_header>
  <id_info>
    <org_study_id>INT.CR.GH2</org_study_id>
    <nct_id>NCT01883492</nct_id>
  </id_info>
  <brief_title>A Prospective Multi-center Study on Total Hip Arthroplasty With E1</brief_title>
  <official_title>A Prospective Multi-center Randomized Study on Total Hip Replacement With E1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objectives of this clinical study include:

        -  Evaluate E1 Wear including early bedding-in process, clinical outcomes on patients who
           received Total Hip Arthroplasty with E1

        -  Compare E1 wear used with CoCr and Biolox Delta heads
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is designed as PROSPECTIVE, RANDOMIZED, MULTI-CENTER Study to compare two
      different materials (CoCr and Delta ceramic) articulating against E1 Highly Crosslinked
      polyethylene in Hip Replacement.

      Patient population is 160 (80 each). Follow-up period is 10 year postoperatively. E1 liners
      with thickness of 4.8mm at 45 degrees position (load bearing direction) will be used in all
      cases.

      Randomization will occur via random number generator by 4 blocks randomization.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 11, 2013</start_date>
  <completion_date type="Anticipated">July 2025</completion_date>
  <primary_completion_date type="Anticipated">July 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Polyethylene Wear</measure>
    <time_frame>10year postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>6month postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>1year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>2year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>3year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>5year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>7year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>10year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC osteoarthritis index</measure>
    <time_frame>6month postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC osteoarthritis index</measure>
    <time_frame>1year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC osteoarthritis index</measure>
    <time_frame>2year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC osteoarthritis index</measure>
    <time_frame>3year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC osteoarthritis index</measure>
    <time_frame>5year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC osteoarthritis index</measure>
    <time_frame>7year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC osteoarthritis index</measure>
    <time_frame>10year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UCLA activity score</measure>
    <time_frame>6month postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UCLA activity score</measure>
    <time_frame>1year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UCLA activity score</measure>
    <time_frame>2year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UCLA activity score</measure>
    <time_frame>3year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UCLA activity score</measure>
    <time_frame>5year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UCLA activity score</measure>
    <time_frame>7year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UCLA activity score</measure>
    <time_frame>10year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic assessment</measure>
    <time_frame>6month postoperatively</time_frame>
    <description>component alignment, positioning change osteolysis or other issue(s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic assessment</measure>
    <time_frame>1year postoperatively</time_frame>
    <description>component alignment, positioning change osteolysis or other issue(s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic assessment</measure>
    <time_frame>2year postoperatively</time_frame>
    <description>component alignment, positioning change osteolysis or other issue(s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic assessment</measure>
    <time_frame>3year postoperatively</time_frame>
    <description>component alignment, positioning change osteolysis or other issue(s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic assessment</measure>
    <time_frame>5year postoperatively</time_frame>
    <description>component alignment, positioning change osteolysis or other issue(s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic assessment</measure>
    <time_frame>7year postoperatively</time_frame>
    <description>component alignment, positioning change osteolysis or other issue(s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic assessment</measure>
    <time_frame>10year postoperatively</time_frame>
    <description>component alignment, positioning change osteolysis or other issue(s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Polyethylene wear</measure>
    <time_frame>6 month postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Polyethylene wear</measure>
    <time_frame>1 year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Polyethylene wear</measure>
    <time_frame>2 year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Polyethylene wear</measure>
    <time_frame>3 year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Polyethylene wear</measure>
    <time_frame>5 year postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Polyethylene wear</measure>
    <time_frame>7 year postoperatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">148</enrollment>
  <condition>Hip Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>BIOLOX delta head</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Uncemented Femoral Stem is inserted into femoral medullary canal. Uncemented Acetabular Cup is inserted into acetabular cavity with or without fixation screw(s).
Acetabular Liner, which is made of E1 highly crosslinked polyethylene, is fitted into Acetabular cup.
Biolox delta head is inserted onto the taper of the Femoral stem, and is articulating against Acetabular Liner made of E1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CoCr head</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Uncemented Femoral Stem is inserted into femoral medullary canal. Uncemented Acetabular Cup is inserted into acetabular cavity with or without fixation screw(s).
Acetabular Liner, which is made of E1 highly crosslinked polyethylene, is fitted into Acetabular cup.
CoCr head is inserted onto the taper of the Femoral stem, and is articulating against Acetabular Liner made of E1.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Femoral Stem</intervention_name>
    <description>JMDN classification/Class III device</description>
    <arm_group_label>BIOLOX delta head</arm_group_label>
    <arm_group_label>CoCr head</arm_group_label>
    <other_name>Taperloc Complete</other_name>
    <other_name>Taperloc Microplasty Complete</other_name>
    <other_name>Taperloc Complete XR123</other_name>
    <other_name>Taperloc Microplasty Complete XR123</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acetabular Cup</intervention_name>
    <description>JMDN classification: Class III device</description>
    <arm_group_label>BIOLOX delta head</arm_group_label>
    <arm_group_label>CoCr head</arm_group_label>
    <other_name>Ringloc Acetabular Cup</other_name>
    <other_name>Regenerex Ringloc+ Acetabular Cup</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acetabular Liner</intervention_name>
    <description>JMDN classification: Class III device</description>
    <arm_group_label>BIOLOX delta head</arm_group_label>
    <arm_group_label>CoCr head</arm_group_label>
    <other_name>E1 Ringloc Liner</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Osteoarthritis

          -  Age between 20 - 75 at the time of operation

          -  Patients with limited co-morbidity -ASA I-III

          -  Patients must be able to understand instructions and be willing to return for follow
             up

        Exclusion Criteria:

          -  In accordance with approved Absolute and Relative Contraindications for use in
             participating countries for E1 liner and Delta Ceramic and CoCr femoral head hip
             system System.

        Absolute contraindications include: infection, sepsis, and osteomyelitis.

        Relative contraindications include:

          1. uncooperative patient or patient with neurologic disorders who are incapable of
             following directions,

          2. osteoporosis,

          3. metabolic disorders which may impair bone formation,

          4. osteomalacia,

          5. distant foci of infections which may spread to the implant site,

          6. rapid joint destruction, marked bone loss or bone resorption apparent on
             roentgenogram, and

          7. vascular insufficiency, muscular atrophy, or neuromuscular disease.

          8. pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hirotsugu Ohashi, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saiseikai Nakatsu Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arihiko Kanaji, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Keio University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Katsufumi Uchiyama, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kitasato University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hironori Kaneko, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kitasato University Kitasato Institute Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Koichi Kinoshita, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fukuoka University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fukuoka University School of Medicine</name>
      <address>
        <city>Fukuoka city</city>
        <state>Fukuoka Prefecture</state>
        <zip>814-0180</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kitasato University School of Medicine</name>
      <address>
        <city>Sagamihara City</city>
        <state>Kanagawa Prefecture</state>
        <zip>252-0374</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saiseikai Nakatsu Hospital</name>
      <address>
        <city>Osaka</city>
        <zip>530-0012</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kitasato University Kitasato Institute Hospital</name>
      <address>
        <city>Tokyo</city>
        <zip>108-8642</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keio University School of Medicine</name>
      <address>
        <city>Tokyo</city>
        <zip>160-8582</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2013</study_first_submitted>
  <study_first_submitted_qc>June 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2013</study_first_posted>
  <last_update_submitted>June 20, 2017</last_update_submitted>
  <last_update_submitted_qc>June 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Only Female</keyword>
  <keyword>Age between 20 - 75 at the time of operation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

